MX154758A - Procedimiento para preparacion de derivados de succinimida - Google Patents

Procedimiento para preparacion de derivados de succinimida

Info

Publication number
MX154758A
MX154758A MX827201A MX720182A MX154758A MX 154758 A MX154758 A MX 154758A MX 827201 A MX827201 A MX 827201A MX 720182 A MX720182 A MX 720182A MX 154758 A MX154758 A MX 154758A
Authority
MX
Mexico
Prior art keywords
sub
group
formula
combined
succinimide derivatives
Prior art date
Application number
MX827201A
Other languages
English (en)
Inventor
Kikuo Ishizumi
Fujio Antoku
Yokio Asami
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP20837981A external-priority patent/JPS58126865A/ja
Priority claimed from JP9576382A external-priority patent/JPH0235749B2/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of MX154758A publication Critical patent/MX154758A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/72—4,7-Endo-alkylene-iso-indoles
    • C07D209/76—4,7-Endo-alkylene-iso-indoles with oxygen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX827201A 1981-12-22 1982-12-07 Procedimiento para preparacion de derivados de succinimida MX154758A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20837981A JPS58126865A (ja) 1981-12-22 1981-12-22 環状イミド誘導体及びその酸付加塩
JP9576382A JPH0235749B2 (ja) 1982-06-03 1982-06-03 Kanjoimidojudotaioyobisonosanfukaen

Publications (1)

Publication Number Publication Date
MX154758A true MX154758A (es) 1987-12-10

Family

ID=26436953

Family Applications (2)

Application Number Title Priority Date Filing Date
MX827201A MX154758A (es) 1981-12-22 1982-12-07 Procedimiento para preparacion de derivados de succinimida
MX9203165A MX9203165A (es) 1981-12-22 1992-06-23 Derivados de succinimida y composicion farmaceutica que los contiene .

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX9203165A MX9203165A (es) 1981-12-22 1992-06-23 Derivados de succinimida y composicion farmaceutica que los contiene .

Country Status (6)

Country Link
US (2) US4507303A (es)
EP (1) EP0082402B1 (es)
AT (1) ATE18910T1 (es)
CA (1) CA1184915A (es)
DE (1) DE3270307D1 (es)
MX (2) MX154758A (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
DE3321969A1 (de) * 1983-06-18 1984-12-20 Troponwerke GmbH & Co KG, 5000 Köln 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
JPH0625181B2 (ja) * 1985-03-27 1994-04-06 住友製薬株式会社 新規なイミド誘導体
JPS61238784A (ja) * 1985-04-17 1986-10-24 Sumitomo Seiyaku Kk コハク酸イミド誘導体及びその酸付加塩
US4812567A (en) * 1985-10-16 1989-03-14 American Home Products Corporation Polycyclic spiroimides with psychotropic activity
CA1286672C (en) * 1985-10-16 1991-07-23 Magid A. Abou-Gharbia Fused bicyclic imides with psychotropic activity
JP2660407B2 (ja) * 1986-09-26 1997-10-08 住友製薬株式会社 新規なイミド誘導体
US4777254A (en) * 1986-12-02 1988-10-11 American Home Products Corp. Cyclic imides as H1 -antagonists
US4797488A (en) * 1987-04-03 1989-01-10 American Home Products Corporation Psychotropic polycyclic imides
US5242911A (en) * 1988-06-17 1993-09-07 Pfizer Inc. Bridged bicyclic imides as anxiolytics and antidepressants
FI911285A0 (fi) * 1988-09-16 1991-03-15 Pfizer Antipsykotiska bicykliska 4-/4-(3-bensisotiazolyl)-1-piperazinyl/butylbryggimider.
US5011841B1 (en) * 1989-11-14 1994-09-06 Pfizer Treatment of depression
FR2654934B1 (fr) * 1989-11-29 1994-09-30 Midy Spa Utilisation de derive [4-(2-pyrimidinyl)-1-piperazinyl] butyliques pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale.
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
JP2800953B2 (ja) * 1990-07-06 1998-09-21 住友製薬株式会社 新規なイミド誘導体
ZA918221B (en) * 1990-10-23 1992-06-24 Akzo Nv 4-(4-or 6-(trifluoromethyl-2-pyridinyl))-1-piperazinyl-alkyl substituted lactams
AU9164591A (en) * 1990-12-14 1992-07-08 New York University Functional interactions between glial s-100b and central nervous system serotonergic neurons
US5330762A (en) * 1992-02-27 1994-07-19 Alza Corporation Tandospiaine antidepressive therapy
US5246711A (en) * 1992-02-27 1993-09-21 Alza Corporation Dosage form for treating dysthymia
US5858407A (en) * 1992-02-27 1999-01-12 Alza Corporation Method for administering tandospirone
US5688518A (en) * 1992-02-27 1997-11-18 Alza Corporation Antidepressive therapy
US5185158A (en) * 1992-02-27 1993-02-09 Alza Corporation Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
US5246710A (en) * 1992-02-27 1993-09-21 Alza Corporation Dosage form for treating cyclothymia
US5521313A (en) * 1994-05-05 1996-05-28 Bristol-Myers Squibb Company Process for preparing certain azapirones
ES2094690B1 (es) * 1994-11-22 1997-08-01 Univ Madrid Complutense Nuevos derivados de imida-piperazinas.
US6312717B1 (en) 1998-07-07 2001-11-06 Bristol-Myers Squibb Company Method for treatment of anxiety and depression
WO2000006163A1 (en) * 1998-07-30 2000-02-10 Bristol-Myers Squibb Company Improved method for treatment of sleep-related respiratory disorders
US6566361B2 (en) 1999-06-30 2003-05-20 Laboratories, Upsa Azapirone pain treatment
US7001911B2 (en) 2000-06-28 2006-02-21 Bristol-Myers Squibb Company Fused cyclic modulators of nuclear hormone receptor function
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
MXPA02012605A (es) 2000-06-28 2003-05-14 Squibb Bristol Myers Co Moduladores selectivos del receptor androgeno y metodo para su identificacion, dise°o y uso.
US6953679B2 (en) 2000-09-19 2005-10-11 Bristol-Myers Squibb Company Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (en) * 2000-09-19 2007-11-28 Bristol-Myers Squibb Company Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
CN1115389C (zh) * 2000-10-08 2003-07-23 南京化工大学 石油加氢过程催化活性促进剂
US20040087548A1 (en) 2001-02-27 2004-05-06 Salvati Mark E. Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US7087636B2 (en) * 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
JP2005527578A (ja) * 2002-04-08 2005-09-15 ランバクシー ラボラトリーズ リミテッド 有用な尿選択的α１Ａアドレナリン受容体遮断薬としてのα，ω−ジカルボキシイミド誘導体
US20040002500A1 (en) * 2002-06-28 2004-01-01 Fabre Kramer Pharmaceutical, Inc. Methods for treating attention deficit disorder
JP2004262812A (ja) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd 眼圧低下剤
CN101880274A (zh) * 2010-06-28 2010-11-10 北大国际医院集团西南合成制药股份有限公司 一种坦度螺酮及其类似物的制备方法
US20130303497A1 (en) 2010-08-05 2013-11-14 Conrig Pharma Aps Deuterated 5-ht1a receptor agonists
CN102344442B (zh) * 2011-08-04 2014-08-13 成都科瑞德医药投资有限责任公司 一种枸橼酸坦度螺酮化合物的晶型及其制备方法和用途
CZ304027B6 (cs) * 2011-08-18 2013-08-28 Farmak, A. S. Zpusob prípravy polymorfu (1R,2S,3R,4S)-N-[(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl]-1-cyklohexylmethyl]-2,3-bicyklo[2.2.1]heptandikarboximidu hydrochloridu
CN103755687B (zh) * 2013-12-25 2015-10-21 四川科瑞德制药有限公司 盐酸坦度螺酮晶型ⅰ及其制备方法
CN106467520A (zh) * 2014-06-06 2017-03-01 四川科瑞德制药股份有限公司 一种草酸坦度螺酮化合物
CN106349226A (zh) * 2014-06-06 2017-01-25 四川科瑞德制药股份有限公司 一种l‑酒石酸坦度螺酮化合物
CN106963766B (zh) * 2016-01-13 2021-09-17 四川科瑞德制药股份有限公司 一种氮杂螺酮类药物组合物及其制备方法
US10758535B1 (en) 2019-04-26 2020-09-01 Sumitomo Dainippon Pharma Co., Ltd. Therapeutic drug for dyskinesia
US11559525B2 (en) 2019-04-26 2023-01-24 Sumitomo Pharma Co., Ltd. Therapeutic drug for dyskinesia
JPWO2022045336A1 (es) 2020-08-31 2022-03-03
CN116283926B (zh) * 2021-12-20 2025-02-25 重庆圣华曦药业股份有限公司 枸橼酸坦度螺酮的制备方法及其在制剂中的应用
CN115611866B (zh) * 2022-10-31 2024-04-23 南京海纳医药科技股份有限公司 一种枸橼酸坦度螺酮的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2928846A (en) * 1957-01-15 1960-03-15 Pfizer & Co C Imides of bicycloheptene adducts
US3184456A (en) * 1960-09-12 1965-05-18 Sterling Drug Inc Reduced maleimide adducts of alpha-phellandrene
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3850921A (en) * 1972-09-20 1974-11-26 I Matuo Derivatives of 2,3-norbornanedicarboxamide
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
DE2907070A1 (de) * 1979-02-23 1980-09-04 Hoechst Ag Heterocyclische spiroverknuepfte amidine und verfahren zu ihrer herstellung
US4305944A (en) * 1980-09-08 1981-12-15 Mead Johnson & Company N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones
US4351939A (en) * 1980-10-16 1982-09-28 Mead Johnson & Company Spiro-quaternary ammonium halides and N-(2-pyrimidinyl)piperazinylalkylazaspiroalkanedione process
JPS57197265A (en) * 1981-05-29 1982-12-03 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and medicament containing the same

Also Published As

Publication number Publication date
ATE18910T1 (de) 1986-04-15
MX9203165A (es) 1992-07-01
EP0082402A2 (en) 1983-06-29
DE3270307D1 (en) 1986-05-07
EP0082402A3 (en) 1983-11-23
CA1184915A (en) 1985-04-02
EP0082402B1 (en) 1986-04-02
US4507303A (en) 1985-03-26
US4543355A (en) 1985-09-24

Similar Documents

Publication Publication Date Title
MX154758A (es) Procedimiento para preparacion de derivados de succinimida
ES480542A1 (es) Metodo para producir derivados de imidazol.
IL65801A (en) 1-substituted spiro-(piperidineoxobenzoxazine)s,their preparation and pharmaceutical compositions containing them
ES552044A0 (es) Un procedimiento para la preparacion de oxindol-carboxamidas triciclicas
IE812683L (en) Thieno-pyridine derivatives
ES8802040A1 (es) Un procedimiento para la preparacion de fenialquil-2,3-dihidrobenzofuranos y los correspondientes dihidrobenzopiranos
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
ES8301971A1 (es) Un proceso para la preparacion de derivados de n-alquilimi- dazoles sustituidos
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
ES8407001A1 (es) Procedimiento para la obtencion de 2-(4-hidroxifenoxi)-propionatos.
DK148804C (da) Fremgangsmaade til fremstilling af 1,2,3,4-tetrahydroquinolin-4-oner
IT1150955B (it) Derivati 3h-naft(1.2-d)-imidazolici il procedimento per la loro preparazione, il loro uso come agenti antiinfiammatori e le composizioni farmaceutiche che li contengono
ES8609233A1 (es) Procedimiento para preparar compuestos intermedios para ob- tener derivados de los acidos 16-fenoxi y 16-fenoxi susti- tuido-prostatrienoicos
IE801382L (en) Piperidines.
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem
SE8301785L (sv) Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning
ES8506606A1 (es) Procedimiento de preparacion de eteres oximas basicos y de sus sales de adicion acidas
ES477709A1 (es) Procedimiento de preparacion de nuevos compuestos cis- y trans-1,5-benzotiacepinicos.
ES477280A1 (es) Procedimiento para la obtencion de un diastereomero especi- fico de eritro-2-(2-aralquilamino-1-hidroxietil)-1,4-benzo- dioxanos.
IE791324L (en) Process for preparing cis-bicylooctylamines.
IE56310B1 (en) Acridanone derivatives
KR830002753A (ko) 5-치환 피라논 화합물의 제조방법
FR2446818A1 (fr) Tetrahydro-2h-benzo(c)pyrroles utiles comme intermediaires